• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

反应堆事故。公共卫生策略及其医学影响。

Reactor accidents. Public health strategies and their medical implications.

作者信息

Becker D V

出版信息

JAMA. 1987 Aug 7;258(5):649-54. doi: 10.1001/jama.258.5.649.

DOI:10.1001/jama.258.5.649
PMID:3612987
Abstract

In a reactor accident with release of radioactivity, the major potential public health risks are likely to result from radioiodines, particularly iodine 131, which can be readily volatilized and dispersed. They are rapidly absorbed and concentrated by the thyroid, which could result in substantial thyroidal radiation. Although some forms of radiation can cause thyroid cancer in humans, 131I has not been shown to do so, and 40 years of safe experience with this radionuclide in routine clinical thyroid testing and treatment has been reassuring. Nevertheless, since 131I has been shown to cause thyroid neoplasms in animals, efforts to minimize unwarranted exposure seem advisable. Potassium iodide, administered at an appropriate time, will effectively block thyroid uptake, but it has potential toxicity and may be difficult to distribute effectively and safely on a large scale in an emergency. Evaluation of the risks and benefits of potassium iodide use is essential to establishing sound public health policy but awaits additional scientific information.

摘要

在发生放射性物质释放的反应堆事故中,主要的潜在公共卫生风险可能来自放射性碘,尤其是碘131,它很容易挥发和扩散。它们会迅速被甲状腺吸收并浓缩,这可能导致甲状腺受到大量辐射。虽然某些形式的辐射可导致人类患甲状腺癌,但尚未表明碘131会导致这种情况,并且在常规临床甲状腺检测和治疗中对这种放射性核素40年的安全使用经验令人放心。然而,由于已表明碘131会导致动物患甲状腺肿瘤,因此尽量减少不必要的暴露似乎是可取的。在适当的时候服用碘化钾将有效地阻止甲状腺摄取,但它有潜在毒性,在紧急情况下可能难以大规模有效且安全地分发。评估使用碘化钾的风险和益处对于制定合理的公共卫生政策至关重要,但这有待更多科学信息。

相似文献

1
Reactor accidents. Public health strategies and their medical implications.反应堆事故。公共卫生策略及其医学影响。
JAMA. 1987 Aug 7;258(5):649-54. doi: 10.1001/jama.258.5.649.
2
The use of iodine as a thyroidal blocking agent in the event of a reactor accident. Report of the Environmental Hazards Committee of the American Thyroid Association.反应堆事故时将碘用作甲状腺阻滞剂。美国甲状腺协会环境危害委员会报告。
JAMA. 1984 Aug 3;252(5):659-61.
3
Potassium iodide for thyroid blockade in a reactor accident: administrative policies that govern its use.反应堆事故中用于甲状腺阻滞的碘化钾:规范其使用的管理政策。
Thyroid. 1997 Apr;7(2):193-7. doi: 10.1089/thy.1997.7.193.
4
Distributing KI pills to minimize thyroid radiation exposure in case of a nuclear accident in France.在法国发生核事故时分发碘化钾片以尽量减少甲状腺辐射暴露。
Nat Clin Pract Endocrinol Metab. 2007 Sep;3(9):611. doi: 10.1038/ncpendmet0593.
5
Iodide.碘化物
Br Med J. 1980 Oct 11;281(6246):988-9. doi: 10.1136/bmj.281.6246.988.
6
Nuclear reactor accidents--the use of KI as a blocking agent against radioiodine uptake in the thyroid--a review.核反应堆事故——使用碘化钾作为阻止甲状腺摄取放射性碘的阻断剂——综述
Health Phys. 1984 Jun;46(6):1265-79. doi: 10.1097/00004032-198406000-00009.
7
Risks in mass distribution of potassium iodide.碘化钾大规模分发中的风险。
Bull N Y Acad Med. 1983 Dec;59(10):1020-7.
8
Physiological basis for the use of potassium iodide as a thyroid blocking agent logistic issues in its distribution.碘化钾作为甲状腺阻滞剂使用的生理基础及其分发中的后勤问题。
Bull N Y Acad Med. 1983 Dec;59(10):1003-8.
9
Indications for using potassium iodide to protect the thyroid from low level internal irradiation.使用碘化钾保护甲状腺免受低水平内照射的指征。
Bull N Y Acad Med. 1983 Dec;59(10):1028-38.
10
Criteria for the administration of KI for thyroid blocking of radioiodine.用于放射性碘甲状腺阻断的碘化钾给药标准。
Health Phys. 1985 Feb;48(2):141-57. doi: 10.1097/00004032-198502000-00001.

引用本文的文献

1
Intrathyroidal feedforward and feedback network regulating thyroid hormone synthesis and secretion.甲状腺内正向和负反馈网络调节甲状腺激素的合成和分泌。
Front Endocrinol (Lausanne). 2022 Sep 15;13:992883. doi: 10.3389/fendo.2022.992883. eCollection 2022.
2
Pregnancy after high therapeutic doses of iodine-131 in differentiated thyroid cancer: potential risks and recommendations.
Eur J Nucl Med. 1993 Mar;20(3):192-4. doi: 10.1007/BF00169997.
3
Cancer risks in thyroid cancer patients.甲状腺癌患者的癌症风险。
Br J Cancer. 1991 Jul;64(1):159-63. doi: 10.1038/bjc.1991.261.